NGF and nitrosative stress in patients with Huntington's disease

Inmaculada Tasset, Fernando Sánchez-López, Eduardo Agüera, Ricardo Fernández-Bolaños, Francisco Manuel Sánchez, Antonio Cruz-Guerrero, Felix Gascón-Luna, Isaac Túnez

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Introduction: Huntington's disease (HD) is a neurodegenerative genetic disorder caused by expansion of polyglutamine repeats in the huntingtin gene and characterised by the loss of striatal and cortical neurons. Few studies to date have focussed on peripheral neurotrophic-factor levels in patients with HD. Objective: To measure plasma NGF levels in Huntington's disease and investigate their correlation with disease intensity. Materials and methods: Nineteen patients with HD and nineteen age- and sex-matched healthy subjects took part in this cross-sectional study. Plasma levels of NGF, BDNF, GDNF, nitrotyrosine, and myeloperoxidase (MPO) were measured; lactate dehydrogenase (LDH) levels were determined and white blood cell (WBC) counts were evaluated. Results: NGF levels were significantly lower, nitrotyrosine levels were higher and LDH activity was greater in HD patients than in healthy subjects. There was no significant difference in MPO levels or WBC counts, whereas the MPO/WBC ratio was considerably higher in HD patients. The data obtained suggested that biochemical and haematological changes correlated with disease severity. Conclusion: NGF levels are lower in HD patients than in healthy subjects. However, further research is required to confirm the role of NGF in HD.

Original languageEnglish (US)
Pages (from-to)133-136
Number of pages4
JournalJournal of the Neurological Sciences
Volume315
Issue number1-2
DOIs
StatePublished - Apr 15 2012
Externally publishedYes

Fingerprint

Huntington Disease
Nerve Growth Factor
Peroxidase
Healthy Volunteers
Leukocyte Count
L-Lactate Dehydrogenase
Glial Cell Line-Derived Neurotrophic Factor
Corpus Striatum
Inborn Genetic Diseases
Brain-Derived Neurotrophic Factor
Nerve Growth Factors
Neurodegenerative Diseases
Leukocytes
Cross-Sectional Studies
Neurons
Research
Genes

Keywords

  • Basal ganglia
  • BDNF
  • GDNF
  • Huntington's disease
  • Neurodegeneration
  • NGF

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Tasset, I., Sánchez-López, F., Agüera, E., Fernández-Bolaños, R., Sánchez, F. M., Cruz-Guerrero, A., ... Túnez, I. (2012). NGF and nitrosative stress in patients with Huntington's disease. Journal of the Neurological Sciences, 315(1-2), 133-136. https://doi.org/10.1016/j.jns.2011.12.014

NGF and nitrosative stress in patients with Huntington's disease. / Tasset, Inmaculada; Sánchez-López, Fernando; Agüera, Eduardo; Fernández-Bolaños, Ricardo; Sánchez, Francisco Manuel; Cruz-Guerrero, Antonio; Gascón-Luna, Felix; Túnez, Isaac.

In: Journal of the Neurological Sciences, Vol. 315, No. 1-2, 15.04.2012, p. 133-136.

Research output: Contribution to journalArticle

Tasset, I, Sánchez-López, F, Agüera, E, Fernández-Bolaños, R, Sánchez, FM, Cruz-Guerrero, A, Gascón-Luna, F & Túnez, I 2012, 'NGF and nitrosative stress in patients with Huntington's disease', Journal of the Neurological Sciences, vol. 315, no. 1-2, pp. 133-136. https://doi.org/10.1016/j.jns.2011.12.014
Tasset I, Sánchez-López F, Agüera E, Fernández-Bolaños R, Sánchez FM, Cruz-Guerrero A et al. NGF and nitrosative stress in patients with Huntington's disease. Journal of the Neurological Sciences. 2012 Apr 15;315(1-2):133-136. https://doi.org/10.1016/j.jns.2011.12.014
Tasset, Inmaculada ; Sánchez-López, Fernando ; Agüera, Eduardo ; Fernández-Bolaños, Ricardo ; Sánchez, Francisco Manuel ; Cruz-Guerrero, Antonio ; Gascón-Luna, Felix ; Túnez, Isaac. / NGF and nitrosative stress in patients with Huntington's disease. In: Journal of the Neurological Sciences. 2012 ; Vol. 315, No. 1-2. pp. 133-136.
@article{6fd8940c9fd54f2ca80ce706faa2bed0,
title = "NGF and nitrosative stress in patients with Huntington's disease",
abstract = "Introduction: Huntington's disease (HD) is a neurodegenerative genetic disorder caused by expansion of polyglutamine repeats in the huntingtin gene and characterised by the loss of striatal and cortical neurons. Few studies to date have focussed on peripheral neurotrophic-factor levels in patients with HD. Objective: To measure plasma NGF levels in Huntington's disease and investigate their correlation with disease intensity. Materials and methods: Nineteen patients with HD and nineteen age- and sex-matched healthy subjects took part in this cross-sectional study. Plasma levels of NGF, BDNF, GDNF, nitrotyrosine, and myeloperoxidase (MPO) were measured; lactate dehydrogenase (LDH) levels were determined and white blood cell (WBC) counts were evaluated. Results: NGF levels were significantly lower, nitrotyrosine levels were higher and LDH activity was greater in HD patients than in healthy subjects. There was no significant difference in MPO levels or WBC counts, whereas the MPO/WBC ratio was considerably higher in HD patients. The data obtained suggested that biochemical and haematological changes correlated with disease severity. Conclusion: NGF levels are lower in HD patients than in healthy subjects. However, further research is required to confirm the role of NGF in HD.",
keywords = "Basal ganglia, BDNF, GDNF, Huntington's disease, Neurodegeneration, NGF",
author = "Inmaculada Tasset and Fernando S{\'a}nchez-L{\'o}pez and Eduardo Ag{\"u}era and Ricardo Fern{\'a}ndez-Bola{\~n}os and S{\'a}nchez, {Francisco Manuel} and Antonio Cruz-Guerrero and Felix Gasc{\'o}n-Luna and Isaac T{\'u}nez",
year = "2012",
month = "4",
day = "15",
doi = "10.1016/j.jns.2011.12.014",
language = "English (US)",
volume = "315",
pages = "133--136",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - NGF and nitrosative stress in patients with Huntington's disease

AU - Tasset, Inmaculada

AU - Sánchez-López, Fernando

AU - Agüera, Eduardo

AU - Fernández-Bolaños, Ricardo

AU - Sánchez, Francisco Manuel

AU - Cruz-Guerrero, Antonio

AU - Gascón-Luna, Felix

AU - Túnez, Isaac

PY - 2012/4/15

Y1 - 2012/4/15

N2 - Introduction: Huntington's disease (HD) is a neurodegenerative genetic disorder caused by expansion of polyglutamine repeats in the huntingtin gene and characterised by the loss of striatal and cortical neurons. Few studies to date have focussed on peripheral neurotrophic-factor levels in patients with HD. Objective: To measure plasma NGF levels in Huntington's disease and investigate their correlation with disease intensity. Materials and methods: Nineteen patients with HD and nineteen age- and sex-matched healthy subjects took part in this cross-sectional study. Plasma levels of NGF, BDNF, GDNF, nitrotyrosine, and myeloperoxidase (MPO) were measured; lactate dehydrogenase (LDH) levels were determined and white blood cell (WBC) counts were evaluated. Results: NGF levels were significantly lower, nitrotyrosine levels were higher and LDH activity was greater in HD patients than in healthy subjects. There was no significant difference in MPO levels or WBC counts, whereas the MPO/WBC ratio was considerably higher in HD patients. The data obtained suggested that biochemical and haematological changes correlated with disease severity. Conclusion: NGF levels are lower in HD patients than in healthy subjects. However, further research is required to confirm the role of NGF in HD.

AB - Introduction: Huntington's disease (HD) is a neurodegenerative genetic disorder caused by expansion of polyglutamine repeats in the huntingtin gene and characterised by the loss of striatal and cortical neurons. Few studies to date have focussed on peripheral neurotrophic-factor levels in patients with HD. Objective: To measure plasma NGF levels in Huntington's disease and investigate their correlation with disease intensity. Materials and methods: Nineteen patients with HD and nineteen age- and sex-matched healthy subjects took part in this cross-sectional study. Plasma levels of NGF, BDNF, GDNF, nitrotyrosine, and myeloperoxidase (MPO) were measured; lactate dehydrogenase (LDH) levels were determined and white blood cell (WBC) counts were evaluated. Results: NGF levels were significantly lower, nitrotyrosine levels were higher and LDH activity was greater in HD patients than in healthy subjects. There was no significant difference in MPO levels or WBC counts, whereas the MPO/WBC ratio was considerably higher in HD patients. The data obtained suggested that biochemical and haematological changes correlated with disease severity. Conclusion: NGF levels are lower in HD patients than in healthy subjects. However, further research is required to confirm the role of NGF in HD.

KW - Basal ganglia

KW - BDNF

KW - GDNF

KW - Huntington's disease

KW - Neurodegeneration

KW - NGF

UR - http://www.scopus.com/inward/record.url?scp=84857996311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857996311&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2011.12.014

DO - 10.1016/j.jns.2011.12.014

M3 - Article

VL - 315

SP - 133

EP - 136

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -